Skip to main content
Figure 2 | Molecular Medicine

Figure 2

From: Recombinant Chimeric Antibody hCAb as a Novel Anti-human Colorectal Carcinoma Agent

Figure 2

Flow cytometry analysis of hCAb’s binding ability to colorectal cancer cell lines. The FACS Results were measured In 3 Independent experiments and expressed as the mean ± SD. A: The FACS data; B: Detection of hCAb’s binding ability to Hce-8693 cell lines by FCM. Hce-8693 cells were stained with hCAb (B1), CAb (B2) or anti-cytomegalovirus IgG (B3), respectively, and then were analyzed by flow cytometry.

Back to article page